M&A Deal Summary

Luitpold Pharmaceuticals Acquires ROXRO PHARMA

On December 13, 2010, Luitpold Pharmaceuticals acquired healthcare services company ROXRO PHARMA

Acquisition Highlights
  • This is Luitpold Pharmaceuticals’ 1st transaction in the Healthcare Services sector.
  • This is Luitpold Pharmaceuticals’ 1st transaction in the United States.
  • This is Luitpold Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary

Date 2010-12-13
Target ROXRO PHARMA
Sector Healthcare Services
Buyer(s) Luitpold Pharmaceuticals
Deal Type Add-on Acquisition
Advisor(s) Goodwin Procter (Legal)

Target

ROXRO PHARMA

Menlo Park, California, United States
ROXRO PHARMA, Inc. is a late-stage specialty pharmaceutical company developing hospital strength acute pain products for convenient use by patients in the home setting.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Luitpold Pharmaceuticals

Shirley, New York, United States

Category Company
Sector Healthcare Services
DESCRIPTION

Luitpold Pharmaceuticals, Inc. manufactures and distributes over 80 pharmaceutical products including Venofer® (iron sucrose injection, USP), the # 1 selling IV iron therapy in the U.S., through its human health subsidiary, American Regent, Inc.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2010 M&A 1 of 1